The author reviews the recent progress in the area of stem cell technology and discusses the obstacles to further development in the U.S..
You are here
P&T® Journal contents for March 2004
Health Care & Law
Three antineoplastic agents are described: intravenous cetuximab for metastatic colorectal cancer, injected pemetrexed for malignant pleural mesothelioma, and injected oxaliplatin for recurrent or metastatic colorectal cancer.
Dr. Howden reviews tegaserod maleate (Zelnorm™) and its role in patients with multiple gastrointestinal problems.
Pharmacists respond to a nationwide survey about their likes and dislikes on the job.
Dr. Prescott reports on a combined thrombolytic/glycoprotein receptor blocker therapy for middle cerebral artery occlusion, a thrombin inhibitor, a low-dose thrombolytic agent, an astrocyte activation modulator, a new investigational agent, amphetamine therapy plus physiotherapy, statins for brain infarction, and recombinant factor VIIa for correcting warfarin anticoagulation.